Mevalonic acid (lithium salt)
|Catalog Number||Pack Size||List Price*||Quantity|
* CHF, excl. 7.7% VAT and shipping costs
You are currently not logged in.
Please register to see prices including your discount. Registration may take up to 24h. For guest orders the standard discount of your institution will apply and discounts are visible on the order confirmation.
35% discount on MedChem product orders above CHF 1'000 !
- 1st November - 31st December 2023
- Not cumulative with the "30% off Screening Libraries Promotion"
MVA (lithium salt)
Mevalonic acid (MVA) lithium salt is a precursor substance of the mevalonate pathway, which is essential for cell growth and proliferation. Mevalonic acid lithium salt is effective in inhibiting Simvastatin (HY-17502)-induced decrease in C2C12 cell viability in vitro. Mevalonic acid lithium salt can be used in studies of myopathy and heart failure.
|Research Field||Metabolic Disease, Neurological Disease, Cardiovascular Disease, Metabolic Enzyme/Protease|
|Format||Solubility: DMSO : 50 mg/mL (ultrasonic);H2O : 100 mg/mL (ultrasonic)|
|Grade||Clinical information: Phase 3|
|Storage Conditions||4°C (Powder, sealed storage, away from moisture)|
|Tech. Data Sheet||View datasheet|
|Link To Supplier||http://www.medchemexpress.com|
|Shipping Details||Room Temperature|
|Material Safety Data Sheet||Download PDF|